Obesity trials in France

In France 118 Also abroad 1939

118 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Angers, Bois-Guillaume, Dijon, Paris, Pessac Cedex, Pierre-Bénite, Poitiers, Saint-Herblain
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Lyon, Marseille, Nice, Paris Cedex 15, Tours Cedex 9
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
No phaseTaking people
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Where
Aix-en-Provence, Besançon, Échirolles, Lille, Lyon, Montpellier, Saint-Etienne, Saint-Grégoire, Sète, Strasbourg
Age
18 years to 75 years
People
300 worldwide
Run by
IHU Strasbourg
See details and how to joinNCT07449520
No phaseNot yet taking people in France
Compulsive Eating and Brain's Reward System in Different Pathologies
Where
Clermont-Ferrand
Age
18 years to 80 years
People
150
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT07923513
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Montpellier, Paris, Saint-Herblain
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
Where
Boulogne-Billancourt, Colmar Cedex, Colombes, Le Coudray, Lyon, Nice, Périgueux, Saint-Grégoire
Age
18 years and over
People
3,900 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07843498 · EU 2026-526188-39-00
No phaseTaking people
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Where
Clermont-Ferrand
Age
18 years to 90 years
People
5,000
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT04375280
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Saint-Priest-en-Jarez, Toulouse
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen, Saint-Priest-en-Jarez, Toulouse
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
No phaseTaking people
Optimized Cardiopulmonary Bypass Flow Strategy Based on Ideal Body Weight in Obese Patients Undergoing Cardiac Surgery
Where
Amiens
Age
18 years and over
People
184
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07917494
Phase 3Not yet taking people in France
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Corbeil Essonnes Cedex, La Tronche, Le Coudray, Nantes, Nantes Cedex 1, Paris, Pierre-Bénite, Poitiers, Rouen, Toulouse cedex 9, Vénissieux
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
Where
Angers, Bordeaux, Grenoble Cedex 09, Montpellier, Pierre-Bénite
Age
18 years and over
People
120 worldwide
Run by
Amgen Inc.
See details and how to join2025-522699-94-00 · EU 2025-522699-94-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Bobigny, Colmar Cedex, Dijon, Lyon, Paris, Pessac, Pierre-Bénite, Thionville, Toulouse Cedex 9, Vénissieux
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Amiens, Béziers, Bron, Dijon, Lille, Montpellier, Nantes, Nice, Paris, Toulon, Toulouse, Tourcoing, Tours, Valenciennes
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
No phaseNot yet taking people in France
Evaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With Obesity
Where
Dijon, Grenoble, Lille, Nice, Paris, Poitiers, Scy-Chazelles, Villeneuve-d'Ascq
Age
18 years to 65 years
People
184
Run by
Axomove
See details and how to joinNCT07903025
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Where
Amiens Cedex 1, Angers, Béziers, Bron, Chambray Les Tours, Dijon, Lille, Montpellier, Nantes Cedex 2, Nice, Paris, Paris Cedex 12, Paris Cedex 15, Paris Cedex 18, Toulon, Toulouse Cedex 9, Tourcoing Cedex, Valenciennes
Age
18 years and over
People
2,787 worldwide
Run by
Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00
No phaseTaking people
Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
Where
Villeurbanne
Age
18 years to 65 years
People
30
Run by
Médipôle Lyon-Villeurbanne
See details and how to joinNCT06600555
No phaseTaking people
Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery
Where
Chambéry
Age
18 years and over
People
165
Run by
Centre Hospitalier Metropole Savoie
See details and how to joinNCT06951893
Phase 3Not yet taking people in France
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Chambray Les Tours, Le Coudray, Lille, Massy, Paris, Pessac, Quint-Fonsegrives, Trélazé, Villeurbanne
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 3Taking people
Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA-1)
Where
Angers, Bordeaux, Grenoble Cedex 9, Montpellier, Pierre-Bénite
Age
18 years and over
People
115 worldwide
Run by
Amgen Inc.
See details and how to join2025-522703-14-00 · EU 2025-522703-14-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Bois-Guillaume, Colmar Cedex, Le Coudray, Paris, Pessac, Pierre-Bénite, Saint-Herblain, Vénissieux
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseNot yet taking people in France
NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity
Where
Lyon, Paris
Age
40 years to 70 years
People
168 worldwide
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07850206
Phase 3Not yet taking people in France
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
Where
Angers, Besançon, Bordeaux, Bron, Dijon, La Tronche, Le Kremlin-Bicêtre, Lille, Marseille, Montpellier, Nancy, Paris, Reims, Rennes, Strasbourg, Toulouse
Age
12 years to 17 years
People
50
Run by
University Hospital, Angers
See details and how to joinNCT07845994 · EU 2024-511114-20-00
No phaseNot yet taking people in France
Nutritional Responses to Acute Exercise Performed on the LipoxMax in Obese Adolescents
Where
Aubière
Age
12 years to 16 years
People
18
Run by
Centre Hospitalier Emile Roux
See details and how to joinNCT07844330
Phase 3Taking people
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Where
Angers, Bron, Lille, Marseille, Paris, Toulouse
Age
12 years to 17 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06439277